Ecofibre FY19 revenue skyrocketed 519 per cent
Image Sourced Shutterstock
Market Herald logo


Be the first with the news that moves the market
  • Hemp product provider Ecofibre saw FY19 revenue increase 519 per cent and profits by 170 per cent
  • Business is flourishing at U.S. operations
  • Ecofibre’s share price is up 5.5 per cent at today’s market close, currently sitting at $3.07 per share

Hemp product providers Ecofibre saw its revenue and profits skyrocket during the 2019 financial year.

Revenue soared 519 per cent, brining it to $35.6 million, while profits after tax were boosted 170 per cent, sitting at $6 million.

Ecofibre operates in the U.S. and Australia. Throughout America, the company produces nutraceuticals for humans and pets, as well as topical creams and salves.

Operations in Australia consist of producing homegrown hemp food products such as protein powder and hemp seed oil.

In partnership with Thomas Jefferson University in the States, the company is looking at developing hemp-based textile products and composite materials.

Managing Director of Ecofibre Eric Wang said the company is focused primarily on the quality, safety, and transparency of the product, alongside education and sustainability.

Ecofibre’s Chairman Barry Lambert pointed out education on the product is very important, specifically in differentiating between hemp and marijuana.

“The difference between hemp and marijuana industries is not well understood,” Barry said.

He continued: “Hemp is cannabis with less that 0.3 per cent Tetrahydrocannabinol (THC), the cannabinoid that gives a high. ‘Street’ marijuana could have in excess 20 per cent THC, 50-70 times stronger than hemp extract.”

Barry clarified for shareholders that Ecofibre is not involved in the marijuana industry.

Ecofibre’s U.S. branch Ananda Health is the company’s highest functioning business, in terms of size and profit. It is expected it will continue this way, with Ecofibre saying it doesn’t see tough medicinal cannabis laws in Australia changing anytime soon.

In the U.S., independent pharmacies stocking Ecofibre’s products grew 510 per cent to 3200 institutions.

Ecofibre’s share price is up 5.5 per cent at today’s market close, currently sitting at $3.07 per share.

EOF by the numbers
More From The Market Herald
Cirralto (ASX:CRO) - Managing Director, Adrian Floate

" Cirralto (ASX:CRO) brings in $400k worth of receipts over Q1

Cirralto (CRO) has released its latest quarterly financial update, revealing it ended September with just under $400,000 in customer receipts.
Wisr (ASX:WZR) - CEO, Anthony Nantes

" Wisr (ASX:WZR) adds $123m in originations to loan book

Wisr (WZR) has added another $123 million in originations to its loan book during the recently completed September quarter.
Humm Group (ASX:HUM) - CEO, Rebecca James

" hummgroup (ASX:HUM) 1Q22 business update

hummgroup (HUM) is trading in the green following the company’s business update for the first quarter of the 2022 financial year.
Laybuy (ASX:LBY) - Managing Director, Gary Rohloff

" Laybuy Group (ASX:LBY) signs new £30 million loan

Laybuy Group (LBY) has signed a new £30 million (A$55.3 million) debt facility with US specialist lenders Partners for Growth.